Bernard GILLY

Chairman of the Board, Independent member
PhD, co-founder, Executive Chairman of Gensight Biologics. In charge of investments.
Bernard Gilly has over 20 years of experience in the financial and pharmaceutical sectors, and as an entrepreneur. 
He was Vice-President R&D for 5 years at Pasteur Mérieux Connaught, the vaccine company that since then has become Sanofi Pasteur. Afterwards, he became the CEO of Transgene from 1992 to 2000, heading the Company's listing and raising over 160 million €. He later joined Sofinnova Partners in Paris (2000-2005). In 2005, he founded and became the CEO of Fovea Pharmaceuticals. After Fovea was acquired by Sanofi in 2009, he became Executive Vice President of the Ophthalmology Division of Sanofi.
In 2011, he founded Pixium Vision and served as Chief Executive Officer from 2012 through 2014.

Dietrich WOLF

Chief Executive Officer
After over 15 year of success in the medtech industry, Dietrich Wolf joined the company in 2014 with a view to establishing HIFU (High Intensity Focused Ultrasound) as a recognized future option in glaucoma care.
He recently worked for Carl Zeiss Meditec on a disruptive new technology in oncology, winning prestigious innovation awards in both Germany and the US. Prior to Zeiss, Dietrich Wolf worked at different business divisions of Dentsply International in the field of dental implants and high-tech ceramics.
Dietrich holds a Master and a PhD in Materials Science and Engineering from the University of Erlangen, Germany. He did executive education programs at St. Gallen Business School in Switzerland, at UNC Keenan-Flagler Business School in Chapel Hill, NC and with Harvard Business School, Boston, MA.

Laurent FARCY

Clinical Affairs Director
In July 2008, Laurent joined Fabrice Romano and Philippe Chapuis to found EYE TECH CARE.
Laurent has more than 16 years experience in clinical trials, 14 of which, in particular, relate to medical devices: former Head of Clinical Affairs at Medicrea (surgical spinal column implants), former head of clinical studies at  Sofradim (Covidien - ex Tyco Healthcare). During these years, Laurent gained enormous experience in writing clinical study protocols, setting up registers, coordinating investigators and establishing relationships with the legal authorities for reimbursement issues.
Laurent Farcy holds a Master's degree in physiology and biochemistry and a DESS (Diploma of Higher Studies) in pharmaceutical and nutritional quality control. He is in  charge of the Clinical Affairs.